This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PharMerica Signs Exclusive Agreement With Innovatix, LLC

PharMerica Corporation (NYSE:PMC), a national leader in institutional and specialty home infusion pharmacy services with more than 90 locations across 45 states, has signed a three-year agreement with Innovatix, LLC, a full service non-acute care group purchasing organization co-owned by subsidiaries of GNYHA Ventures and Premier, Inc. (Nasdaq:PINC).

Under the agreement, Innovatix will serve as PharMerica’s exclusive GPO beginning January 1, 2014, and will support PharMerica’s institutional and specialty pharmacy purchasing needs through Innovatix’s network of pharmaceutical and ancillary suppliers. Innovatix will also work with Premier, a leading healthcare improvement company, to ensure Pharmerica is using appropriate products to support its contracting needs.

Additionally, PharMerica will be a member of InnovatixCares, LLC, a new population health management network, whose objective is to achieve better patient care through effective integration of post-acute care providers and emerging Accountable Care Organizations (ACO). InnovatixCares is working with Premier’s PACT Population Health Collaborative to create a comprehensive ACO solution linking providers across the care continuum.

“At the conclusion of a competitive proposal process, we are pleased that PharMerica has chosen Innovatix as its exclusive purchasing organization,” Innovatix President and CEO John P. Sganga said. “By leveraging our pharmacy expertise and the extensive portfolio we share with our national partner Premier, Inc., we believe Innovatix will deliver exceptional value and unparalleled service to PharMerica.”

Commenting about the selection process, Greg Weishar, President and CEO of PharMerica said, “Our selection of Innovatix came after a lengthy and thorough process. Choosing to partner with Innovatix represented the best choice in light of our own strategic initiatives and market expansion into home infusion and specialty. Additionally, we believe ACOs will play an emerging role in coordinating patient care in the years ahead and believe Innovatix is well positioned to assist us in partnering with ACOs, hospitals and physicians.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs